314 related articles for article (PubMed ID: 7926017)
1. Inhibition of lipolysis and lipogenesis in isolated rat adipocytes with AICAR, a cell-permeable activator of AMP-activated protein kinase.
Sullivan JE; Brocklehurst KJ; Marley AE; Carey F; Carling D; Beri RK
FEBS Lett; 1994 Oct; 353(1):33-6. PubMed ID: 7926017
[TBL] [Abstract][Full Text] [Related]
2. Regulation of visceral and subcutaneous adipocyte lipolysis by acute AICAR-induced AMPK activation.
Anthony NM; Gaidhu MP; Ceddia RB
Obesity (Silver Spring); 2009 Jul; 17(7):1312-7. PubMed ID: 19214174
[TBL] [Abstract][Full Text] [Related]
3. 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
Corton JM; Gillespie JG; Hawley SA; Hardie DG
Eur J Biochem; 1995 Apr; 229(2):558-65. PubMed ID: 7744080
[TBL] [Abstract][Full Text] [Related]
4. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
Gaidhu MP; Fediuc S; Ceddia RB
J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
[TBL] [Abstract][Full Text] [Related]
5. Control of p70 ribosomal protein S6 kinase and acetyl-CoA carboxylase by AMP-activated protein kinase and protein phosphatases in isolated hepatocytes.
Krause U; Bertrand L; Hue L
Eur J Biochem; 2002 Aug; 269(15):3751-9. PubMed ID: 12153572
[TBL] [Abstract][Full Text] [Related]
6. AMPK activation by A-769662 and 991 does not affect catecholamine-induced lipolysis in human adipocytes.
Kopietz F; Berggreen C; Larsson S; Säll J; Ekelund M; Sakamoto K; Degerman E; Holm C; Göransson O
Am J Physiol Endocrinol Metab; 2018 Nov; 315(5):E1075-E1085. PubMed ID: 30253109
[TBL] [Abstract][Full Text] [Related]
7. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
[TBL] [Abstract][Full Text] [Related]
8. 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) inhibits insulin-stimulated glucose transport in 3T3-L1 adipocytes.
Salt IP; Connell JM; Gould GW
Diabetes; 2000 Oct; 49(10):1649-56. PubMed ID: 11016448
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glucocorticoid-induced apoptosis with 5-aminoimidazole-4-carboxamide ribonucleoside, a cell-permeable activator of AMP-activated protein kinase.
Stefanelli C; Stanic I; Bonavita F; Flamigni F; Pignatti C; Guarnieri C; Caldarera CM
Biochem Biophys Res Commun; 1998 Feb; 243(3):821-6. PubMed ID: 9500985
[TBL] [Abstract][Full Text] [Related]
10. Prolonged AICAR-induced AMP-kinase activation promotes energy dissipation in white adipocytes: novel mechanisms integrating HSL and ATGL.
Gaidhu MP; Fediuc S; Anthony NM; So M; Mirpourian M; Perry RL; Ceddia RB
J Lipid Res; 2009 Apr; 50(4):704-15. PubMed ID: 19050316
[TBL] [Abstract][Full Text] [Related]
11. AMPK activation regulates apoptosis, adipogenesis, and lipolysis by eIF2alpha in adipocytes.
Dagon Y; Avraham Y; Berry EM
Biochem Biophys Res Commun; 2006 Feb; 340(1):43-7. PubMed ID: 16377306
[TBL] [Abstract][Full Text] [Related]
12. AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle.
Merrill GF; Kurth EJ; Hardie DG; Winder WW
Am J Physiol; 1997 Dec; 273(6):E1107-12. PubMed ID: 9435525
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of hepatocytic AMP-activated protein kinase by okadaic acid and other autophagy-suppressive toxins.
Samari HR; Møller MT; Holden L; Asmyhr T; Seglen PO
Biochem J; 2005 Mar; 386(Pt 2):237-44. PubMed ID: 15461583
[TBL] [Abstract][Full Text] [Related]
14. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR.
Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of fatty acid and cholesterol synthesis by stimulation of AMP-activated protein kinase.
Henin N; Vincent MF; Gruber HE; Van den Berghe G
FASEB J; 1995 Apr; 9(7):541-6. PubMed ID: 7737463
[TBL] [Abstract][Full Text] [Related]
16. Prior serum- and AICAR-induced AMPK activation in primary human myocytes does not lead to subsequent increase in insulin-stimulated glucose uptake.
Al-Khalili L; Krook A; Zierath JR; Cartee GD
Am J Physiol Endocrinol Metab; 2004 Sep; 287(3):E553-7. PubMed ID: 15149951
[TBL] [Abstract][Full Text] [Related]
17. Effects of AMPK activation on lipolysis in primary rat adipocytes: studies at different glucose concentrations.
Szkudelski T; Szkudelska K
Arch Physiol Biochem; 2017 Feb; 123(1):43-49. PubMed ID: 27656952
[TBL] [Abstract][Full Text] [Related]
18. Biguanides and thiazolidinediones inhibit stimulated lipolysis in human adipocytes through activation of AMP-activated protein kinase.
Bourron O; Daval M; Hainault I; Hajduch E; Servant JM; Gautier JF; Ferré P; Foufelle F
Diabetologia; 2010 Apr; 53(4):768-78. PubMed ID: 20043143
[TBL] [Abstract][Full Text] [Related]
19. Control of hepatic fatty acid oxidation by 5'-AMP-activated protein kinase involves a malonyl-CoA-dependent and a malonyl-CoA-independent mechanism.
Velasco G; Geelen MJ; Guzmán M
Arch Biochem Biophys; 1997 Jan; 337(2):169-75. PubMed ID: 9016810
[TBL] [Abstract][Full Text] [Related]
20. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
